Using AI - SimBioSys and General Inception's cancer pact
Precision oncology innovator SimBioSys and General Inception have joined forces in a strategic partnership aimed at revolutionizing cancer drug development.
Stay updated with breaking news from General Inception. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Precision oncology innovator SimBioSys and General Inception have joined forces in a strategic partnership aimed at revolutionizing cancer drug development.
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients It can provide more precise patient dosing to reduce side effects, increase efficiency and reduce wastage CHICAGO, IL & PALO ALTO, CA – 3 April 2024 – Si...
ASU ranks among the Top 5 research institutions without a medical school for inventions, U.S. patents secured and startups launched.
/PRNewswire/ -- OmniSync Incorporated has been awarded a Small Business Innovation Research (SBIR) Phase III contract by the US Air Force to deliver and...
San Diego-based OmniSync, which is backed by Govtech Fund, Longley Capital, General Inception, Keshif Ventures, and angels, said it has received a SBIR Phase III contract. The contract comes rom the US Air